Biomedical Engineering Reference
In-Depth Information
37. Chirmule, N., Propert, K., Magosin, S.
et al
. (1999) Immune responses to adenovirus and
adeno-associated virus in humans.
Gene Therapy
,
6
(9), 1574-1583.
38. Buning, H., Perabo, L., Coutelle, O.
et al
. (2008) Recent developments in adeno-associated virus
vector technology.
Journal of Gene Medicine
,
10
(7), 717-733.
39. Rowe, W.P., Huebner, R.J., Gilmore, L.K.
et al
. (1953) Isolation of a cytopathogenic agent
from human adenoids undergoing spontaneous degeneration in tissue culture.
Proceedings of the
Society for Experimental Biology and Medicine
,
84
(3), 570-573.
40. Ginsberg, H.S. (1984) The Adenoviruses, Plenum Press, New York.
41. Bergelson, J.M., Cunningham, J.A., Droguett, G.
et al
. (1997) Isolation of a common receptor
for coxsackie B viruses and adenoviruses 2 and 5.
Science
,
275
(5304), 1320-1323.
42. Parker, A.L., Waddington, S.N., Nicol, C.G.
et al
. (2006) Multiple vitamin K-dependent coag-
ulation zymogens promote adenovirus-mediated gene delivery to hepatocytes.
Blood
,
108
(8),
2554-2561.
43. Waddington, S.N., Parker, A.L., Havenga, M.
et al
. (2007) Targeting of adenovirus serotype 5
(Ad5) and 5/47 pseudotyped vectors
in vivo
: fundamental involvement of coagulation factors
and redundancy of CAR binding by Ad5.
Journal of Virology
,
81
(17), 9568-9571.
44. Wickham, T.J., Mathias, P., Cheresh, D.A. and Nemerow, G.R. (1993) Integrins
α
v
β
3and
α
v
β
5
promote adenovirus internalization but not virus attachment.
Cell
,
73
(2), 309-319.
45. Graham, F.L., Smiley, J., Russell, W.C. and Nairn, R. (1977) Characteristics of a human cell
line transformed by DNA from human adenovirus type 5.
Journal of General Virology
,
36
(1),
59-74. Ad5 vectors and suitable packaging cells.
46. Hearing, P., Samulski, R.J., Wishart, W.L. and Shenk, T. (1987) Identification of a repeated
sequence element required for efficient encapsidation of the adenovirus type 5 chromosome.
Journal of Virology
,
61
(8), 2555-2558.
47. Shen, W.Y., Lai, M.C., Beilby, J.
et al
. (2001) Combined effect of cyclosporine and sirolimus on
improving the longevity of recombinant adenovirus-mediated transgene expression in the retina.
Archives of Ophthalmology
,
119
(7), 1033-1043.
48. Yap, J., O'Brien, T., Tazelaar, H.D. and McGregor, C.G. (1997) Immunosuppression prolongs
adenoviral mediated transgene expression in cardiac allograft transplantation.
Cardiovascular
Research
,
35
(3), 529-535.
49. Engelhardt, J.F., Ye, X., Doranz, B. and Wilson, J.M. (1994) Ablation of E2A in recombinant
adenoviruses improves transgene persistence and decreases inflammatory response in mouse
liver.
Proceedings of the National Academy of Sciences of the United States of America
,
91
(13),
6196-6200.
50. Qian, H.S., Channon, K., Neplioueva, V.
et al
. (2001) Improved adenoviral vector for vascular
gene therapy : beneficial effects on vascular function and inflammation.
Circulation Research
,
88
(9), 911-917.
51. Wen, S., Schneider, D.B., Driscoll, R.M.
et al
. (2000) Second-generation adenoviral vectors do
not prevent rapid loss of transgene expression and vector DNA from the arterial wall.
Arte-
riosclerosis, Thrombosis, and Vascular Biology
,
20
(6), 1452-1458.
52. Kumar-Singh, R., Yamashita, C.K., Tran, K. and Farber, D.B. (2000) Construction of encap-
sidated (gutted) adenovirus minichromosomes and their application to rescue of photoreceptor
degeneration.
Methods in Enzymology
,
316
, 724-743.
